Native Mass Spectrometry Combined With Enzymatic Dissection Unravels Glycoform Heterogeneity of Biopharmaceuticals
Nature Communications - United Kingdom
doi 10.1038/s41467-018-04061-7
Full Text
Open PDFAbstract
Available in full text
Date
April 30, 2018
Authors
Publisher
Springer Science and Business Media LLC